KR101649541B1 - 건강한 노화 및 장수를 예측하고 증진하기 위하여 ｆｏｘｏ３ａ 다형성 및 일배체형을 사용하는 방법 - Google Patents

건강한 노화 및 장수를 예측하고 증진하기 위하여 ｆｏｘｏ３ａ 다형성 및 일배체형을 사용하는 방법 Download PDF

Info

Publication number
KR101649541B1
KR101649541B1 KR1020117005559A KR20117005559A KR101649541B1 KR 101649541 B1 KR101649541 B1 KR 101649541B1 KR 1020117005559 A KR1020117005559 A KR 1020117005559A KR 20117005559 A KR20117005559 A KR 20117005559A KR 101649541 B1 KR101649541 B1 KR 101649541B1
Authority
KR
South Korea
Prior art keywords
allele
nucleic acid
foxo3a
seq
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020117005559A
Other languages
English (en)
Korean (ko)
Other versions
KR20110057147A (ko
Inventor
티모시 애치슨 돈론
브래들리 존 윌콕스
제이. 다비드 커브
Original Assignee
쿠아키니 메디컬 센터
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41669598&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR101649541(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 쿠아키니 메디컬 센터 filed Critical 쿠아키니 메디컬 센터
Publication of KR20110057147A publication Critical patent/KR20110057147A/ko
Application granted granted Critical
Publication of KR101649541B1 publication Critical patent/KR101649541B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
    • C12Q2535/125—Allele specific primer extension
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
KR1020117005559A 2008-08-10 2009-08-10 건강한 노화 및 장수를 예측하고 증진하기 위하여 ｆｏｘｏ３ａ 다형성 및 일배체형을 사용하는 방법 Active KR101649541B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8772208P 2008-08-10 2008-08-10
US61/087,722 2008-08-10

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020167022020A Division KR20160102081A (ko) 2008-08-10 2009-08-10 건강한 노화 및 장수를 예측하고 증진하기 위하여 ｆｏｘｏ３ａ 다형성 및 일배체형을 사용하는 방법

Publications (2)

Publication Number Publication Date
KR20110057147A KR20110057147A (ko) 2011-05-31
KR101649541B1 true KR101649541B1 (ko) 2016-08-19

Family

ID=41669598

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020167022020A Abandoned KR20160102081A (ko) 2008-08-10 2009-08-10 건강한 노화 및 장수를 예측하고 증진하기 위하여 ｆｏｘｏ３ａ 다형성 및 일배체형을 사용하는 방법
KR1020117005559A Active KR101649541B1 (ko) 2008-08-10 2009-08-10 건강한 노화 및 장수를 예측하고 증진하기 위하여 ｆｏｘｏ３ａ 다형성 및 일배체형을 사용하는 방법

Family Applications Before (1)

Application Number Title Priority Date Filing Date
KR1020167022020A Abandoned KR20160102081A (ko) 2008-08-10 2009-08-10 건강한 노화 및 장수를 예측하고 증진하기 위하여 ｆｏｘｏ３ａ 다형성 및 일배체형을 사용하는 방법

Country Status (9)

Country Link
US (3) US20110212447A1 (enExample)
EP (1) EP2324127B1 (enExample)
JP (1) JP5814119B2 (enExample)
KR (2) KR20160102081A (enExample)
CN (1) CN102177255B (enExample)
AU (1) AU2009282172B2 (enExample)
CA (1) CA2733597C (enExample)
DK (1) DK2324127T3 (enExample)
WO (1) WO2010019519A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2733597C (en) * 2008-08-10 2019-02-26 Kuakini Medical Center Method of using foxo3a polymorphisms and haplotypes to predict and promote healthy aging and longevity
US8990135B2 (en) * 2010-06-15 2015-03-24 The Regents Of The University Of Michigan Personalized health risk assessment for critical care
CN103233001B (zh) * 2012-06-25 2016-11-02 西北农林科技大学 秦川牛FoxO1基因单核苷酸多态性分子标记的检测方法与应用
KR102017562B1 (ko) * 2013-03-13 2019-09-03 (주)아모레퍼시픽 미백 효능 물질의 스크리닝 방법
WO2017062751A1 (en) * 2015-10-08 2017-04-13 The Regents Of The University Of California Compounds and methods for promoting stress resistance
WO2018183353A1 (en) * 2017-03-27 2018-10-04 Cardax Pharma, Inc. Small molecule compounds to support healthy human aging
CN110915165B (zh) 2017-05-12 2023-05-26 麻省理工学院 用于共享私有数据的计算机实现的方法和装置
WO2019156591A1 (en) * 2018-02-12 2019-08-15 Limited Liability Company "Gero" Methods and systems for prediction of frailty background
CN111235250A (zh) * 2020-03-31 2020-06-05 中国科学院昆明动物研究所 与健康老龄相关的关键通路及其外周血dna甲基化位点标志物和应用
CN115466321B (zh) * 2022-09-23 2024-03-22 南方医科大学珠江医院 FOXO3a-DRI肽段、其药物组合物及应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060003359A1 (en) 2004-06-03 2006-01-05 The Johns Hopkins University Methods of screening for cell proliferation or neoplastic disorders
US20060068414A1 (en) 2004-07-26 2006-03-30 Kennedy Brian K Identification of aging genes through large-scale analysis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7932049B2 (en) 2002-12-23 2011-04-26 University Of Massachusetts Methods of identifying longevity modulators and therapeutic methods of use thereof
WO2005004814A2 (en) 2003-07-02 2005-01-20 Elixir Pharmaceuticals, Inc. Sirt1 and genetic disorders
US20060069049A1 (en) 2003-12-29 2006-03-30 President And Fellows Of Harvard College Methods and reagents related to foxo
US20070118398A1 (en) * 2005-11-18 2007-05-24 Flicker Technologies, Llc System and method for estimating life expectancy and providing customized advice for improving life expectancy
JP5292569B2 (ja) * 2006-11-10 2013-09-18 国立大学法人名古屋大学 抗老化転写因子活性化剤及びその利用
CA2733597C (en) * 2008-08-10 2019-02-26 Kuakini Medical Center Method of using foxo3a polymorphisms and haplotypes to predict and promote healthy aging and longevity

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060003359A1 (en) 2004-06-03 2006-01-05 The Johns Hopkins University Methods of screening for cell proliferation or neoplastic disorders
US20060068414A1 (en) 2004-07-26 2006-03-30 Kennedy Brian K Identification of aging genes through large-scale analysis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Kim, JR., et al., Obesity, Vol.14(2), pp.188-193 (2006. 2.)
Kuningas, M., et al., Eur. J. Hum. Genet., Vol.15, pp.294-301 (2007. 01.)*

Also Published As

Publication number Publication date
EP2324127A2 (en) 2011-05-25
AU2009282172B2 (en) 2016-06-02
US20110212447A1 (en) 2011-09-01
KR20110057147A (ko) 2011-05-31
JP5814119B2 (ja) 2015-11-17
AU2009282172A1 (en) 2010-02-18
US20130295566A1 (en) 2013-11-07
WO2010019519A3 (en) 2010-05-27
DK2324127T3 (en) 2015-04-27
EP2324127B1 (en) 2015-01-21
HK1158271A1 (en) 2012-07-13
US20150337383A1 (en) 2015-11-26
CN102177255B (zh) 2015-12-16
WO2010019519A2 (en) 2010-02-18
CN102177255A (zh) 2011-09-07
KR20160102081A (ko) 2016-08-26
EP2324127A4 (en) 2012-06-13
CA2733597C (en) 2019-02-26
CA2733597A1 (en) 2010-02-18
JP2011530312A (ja) 2011-12-22

Similar Documents

Publication Publication Date Title
KR101649541B1 (ko) 건강한 노화 및 장수를 예측하고 증진하기 위하여 ｆｏｘｏ３ａ 다형성 및 일배체형을 사용하는 방법
US8053190B2 (en) Susceptibility genes for age-related maculopathy (ARM) on chromosome 10q26
Parchwani et al. Analysis of association of angiotensin II type 1 receptor gene A1166C gene polymorphism with essential hypertension
Hubacek et al. The FTO variant is associated with chronic complications of diabetes mellitus in Czech population
EP2094868A2 (en) Sirtuin polymorphisms and methods of use thereof
US20100255475A1 (en) Diagnostics and therapeutics for osteoporosis
US20030170678A1 (en) Genetic markers for Alzheimer's disease and methods using the same
Ding et al. Polymorphisms in DNA methylation–related genes are linked to the phenotype of Machado-Joseph disease
US20070299025A1 (en) Method for Detecting the Risk of Cardiovascular Diseases Such as Acute Myocardial Infarction and Coronary Heart Disease By Analysing Defesin
HK1158271B (en) Method of using foxo3a polymorphisms and haplotypes to predict and promote healthy aging and longevity
Hansen et al. The rhesus monkey: A nonhuman primate model for T2DM-associated gene screening
US8236497B2 (en) Methods of diagnosing cardiovascular disease
US20040023225A1 (en) Methods and compositions for identifying risk factors for abnormal lipid levels and the diseases and disorders associated therewith
KR20130027093A (ko) Ｋｌｏｔｈｏ 유전자의 단일염기다형을 이용한 심혈관계 질환 예측 방법
Khodyrev et al. The analysis of association between type 2 diabetes and polymorphic markers in the CDKAL1 gene and in the HHEX/IDE locus
US20080194419A1 (en) Genetic Association of Polymorphisms in the Atf6-Alpha Gene with Insulin Resistance Phenotypes
US20100184839A1 (en) Allelic polymorphism associated with diabetes
Hansen et al. The Rhesus Monkey: A Nonhuman Primate Model For T2DM-Associated Gene Screening. J Diabetes Metab 2: 150. doi: 10.4172/2155-6156.1000150 Page 2 of 7 Volume 2• Issue 7• 1000150 J Diabetes Metab ISSN: 2155-6156 JDM, an open access journal nucleotide and amino acid levels; c) 89 percent of the rhesus monkey genes are syngenically aligned with the corresponding human genes; and d) an extraordinary amount of physiological similarity exists between rhesus monkeys and humans [13]
WO2011004345A1 (en) Upstream binding protein 1 polymorphisms and their use for prognosing or diagnosing arterial blood pressure
WO2006084133A2 (en) Methods for dosing l-thyroxine
CA2517986A1 (en) Chromosome 1p36 polymorphisms and low bone mineral density

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

J202 Request for trial for correction [limitation]
PJ0202 Trial for correction

St.27 status event code: A-5-5-V10-V11-apl-PJ0202

J301 Trial decision

Free format text: TRIAL NUMBER: 2016105000117; TRIAL DECISION FOR CORRECTION REQUESTED 20161017

Effective date: 20170731

PJ1301 Trial decision

St.27 status event code: A-5-5-V10-V15-crt-PJ1301

Decision date: 20170731

Appeal event data comment text: Appeal Kind Category : Correction, Appeal Ground Text : 1649541

Appeal request date: 20161017

Appellate body name: Patent Examination Board

Decision authority category: Office appeal board

Decision identifier: 2016105000117

PG1701 Publication of correction

St.27 status event code: A-5-5-P10-P19-oth-PG1701

Patent document republication publication date: 20170810

Republication note text: Request for Public Notice of Correction Statement

Gazette number: 1016495410000

Gazette reference publication date: 20160819

FPAY Annual fee payment

Payment date: 20190619

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 10